These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 28339500)

  • 21. Birth outcomes following zidovudine therapy in pregnant women.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1994 Jun; 43(22):409, 415-6. PubMed ID: 8003111
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Birth prevalence of congenital cytomegalovirus among infants of HIV-infected women on prenatal antiretroviral prophylaxis in South Africa.
    Manicklal S; van Niekerk AM; Kroon SM; Hutto C; Novak Z; Pati SK; Chowdhury N; Hsiao NY; Boppana SB
    Clin Infect Dis; 2014 May; 58(10):1467-72. PubMed ID: 24567248
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Maternal and obstetric complications among HIV-infected women treated with highly active antiretroviral treatment at a Regional Hospital in Durban, South Africa.
    Sebitloane HM; Moodley J
    Niger J Clin Pract; 2017 Nov; 20(11):1360-1367. PubMed ID: 29303121
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antiretroviral treatment and prevention of peripartum and postnatal HIV transmission in West Africa: evaluation of a two-tiered approach.
    Tonwe-Gold B; Ekouevi DK; Viho I; Amani-Bosse C; Toure S; Coffie PA; Rouet F; Becquet R; Leroy V; El-Sadr WM; Abrams EJ; Dabis F
    PLoS Med; 2007 Aug; 4(8):e257. PubMed ID: 17713983
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Decision guides for antiretroviral treatment in pregnancy].
    Malinverni R; Rudin C
    Ther Umsch; 1998 May; 55(5):323-8. PubMed ID: 9643130
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety and effectiveness of antiretroviral therapies for HIV-infected women and their infants and children: protocol for a systematic review and network meta-analysis.
    Tricco AC; Antony J; Angeliki VA; Ashoor H; Hutton B; Hemmelgarn BR; Moher D; Finkelstein Y; Gough K; Straus SE
    Syst Rev; 2014 May; 3():51. PubMed ID: 24887455
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lack of long-term effects of in utero exposure to zidovudine among uninfected children born to HIV-infected women. Pediatric AIDS Clinical Trials Group Protocol 219/076 Teams.
    Culnane M; Fowler M; Lee SS; McSherry G; Brady M; O'Donnell K; Mofenson L; Gortmaker SL; Shapiro DE; Scott G; Jimenez E; Moore EC; Diaz C; Flynn PM; Cunningham B; Oleske J
    JAMA; 1999 Jan; 281(2):151-7. PubMed ID: 9917118
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safety of agents used to prevent mother-to-child transmission of HIV: is there any cause for concern?
    Thorne C; Newell ML
    Drug Saf; 2007; 30(3):203-13. PubMed ID: 17343429
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Efficiency and side effects of antiretroviral treatment of HIV infected pregnant women].
    Simon T; Funke AM; Hero B; Reiser-Hartwig S; Fuhrmann U
    Zentralbl Gynakol; 2002; 124(8-9):413-7. PubMed ID: 12655470
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Raltegravir versus efavirenz in antiretroviral-naive pregnant women living with HIV (NICHD P1081): an open-label, randomised, controlled, phase 4 trial.
    João EC; Morrison RL; Shapiro DE; Chakhtoura N; Gouvèa MIS; de Lourdes B Teixeira M; Fuller TL; Mmbaga BT; Ngocho JS; Njau BN; Violari A; Mathiba R; Essack Z; Pilotto JHS; Moreira LF; Rolon MJ; Cahn P; Prommas S; Cressey TR; Chokephaibulkit K; Werarak P; Laimon L; Hennessy R; Frenkel LM; Anthony P; Best BM; Siberry GK; Mirochnick M
    Lancet HIV; 2020 May; 7(5):e322-e331. PubMed ID: 32386720
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antiretroviral use during pregnancy for treatment or prophylaxis.
    Sturt AS; Read JS
    Expert Opin Pharmacother; 2011 Aug; 12(12):1875-85. PubMed ID: 21534886
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In utero exposure to zidovudine and heart anomalies in the ANRS French perinatal cohort and the nested PRIMEVA randomized trial.
    Sibiude J; Le Chenadec J; Bonnet D; Tubiana R; Faye A; Dollfus C; Mandelbrot L; Delmas S; Lelong N; Khoshnood B; Warszawski J; Blanche S;
    Clin Infect Dis; 2015 Jul; 61(2):270-80. PubMed ID: 25838291
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of maternal vitamin D
    Sudfeld CR; Manji KP; Duggan CP; Aboud S; Muhihi A; Sando DM; Al-Beity FMA; Wang M; Fawzi WW
    Trials; 2017 Sep; 18(1):411. PubMed ID: 28870263
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 'Mothers moving towards empowerment' intervention to reduce stigma and improve treatment adherence in pregnant women living with HIV in Botswana: study protocol for a pragmatic clinical trial.
    Poku OB; Ho-Foster AR; Entaile P; Misra S; Mehta H; Rampa S; Goodman M; Arscott-Mills T; Eschliman E; Jackson V; Melese T; Becker TD; Eisenberg M; Link B; Go V; Opondo PR; Blank MB; Yang LH
    Trials; 2020 Oct; 21(1):832. PubMed ID: 33028387
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Current treatment strategies, complications and considerations for the use of HIV antiretroviral therapy during pregnancy.
    Senise JF; Castelo A; Martínez M
    AIDS Rev; 2011; 13(4):198-213. PubMed ID: 21975356
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reassuring Birth Outcomes With Tenofovir/Emtricitabine/Efavirenz Used for Prevention of Mother-to-Child Transmission of HIV in Botswana.
    Zash R; Souda S; Chen JY; Binda K; Dryden-Peterson S; Lockman S; Mmalane M; Makhema J; Essex M; Shapiro R
    J Acquir Immune Defic Syndr; 2016 Apr; 71(4):428-36. PubMed ID: 26379069
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Absence of cardiac toxicity of zidovudine in infants. Pediatric Pulmonary and Cardiac Complications of Vertically Transmitted HIV Infection Study Group.
    Lipshultz SE; Easley KA; Orav EJ; Kaplan S; Starc TJ; Bricker JT; Lai WW; Moodie DS; Sopko G; McIntosh K; Colan SD
    N Engl J Med; 2000 Sep; 343(11):759-66. PubMed ID: 10984563
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
    Brocklehurst P; Volmink J
    Cochrane Database Syst Rev; 2002; (2):CD003510. PubMed ID: 12076484
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preterm delivery risk in women initiating antiretroviral therapy to prevent HIV mother-to-child transmission.
    Short CE; Douglas M; Smith JH; Taylor GP
    HIV Med; 2014 Apr; 15(4):233-8. PubMed ID: 24025074
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
    Brocklehurst P; Volmink J
    Cochrane Database Syst Rev; 2002; (1):CD003510. PubMed ID: 11869666
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.